ARCHIVES

CAM Therapies Should Be Held to Conventional Standards and Congress Should Toughen Dietary Supplements Act, IOM Panel Says.

This article is from The Cancer Letter archive.

Vol. 31 No. 03 | January 21, 2005

Download PDF Visit The Full Archive

Related Articles

Oncology Groups Oppose Proposed Cuts In Medicare Payments For Cancer Drugs

October 11, 2002

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979

Interview: “People don’t understand Clinical Trials.

September 5, 1997

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

DCBD Board Votes down, Then Approves Organ Systems PA

November 10, 1989